Neoplasms and nodules
Conditions
Interventions
Xingxiao pill treatment group:NA
Sponsors
East Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: • Age 18-80 years old, gender unlimited; • Diagnosed as tumor patients (all tumor patients must have pathological diagnosis without limitation, including but not limited to solid tumor after surgery, maintenance period after standard treatment, advanced malignant tumors such as advanced liver cancer, advanced pancreatic cancer, etc.) or nodular diseases (including but not limited to breast nodules, lung nodules, thyroid nodules, lymphatic nodules, uterine fibroids, intestinal polyps, etc.); • Suitable for Xingxiao pill treatment (evaluated by the investigator); • Agree to participate in this clinical trial and voluntarily sign informed consent
Exclusion criteria
Exclusion criteria: • Contraindicated patients, such as those who like to drink cold water, are afraid of heat, and have fever; • Patients who are pregnant, breastfeeding or have the possibility of becoming pregnant or who plan to become pregnant; • Patients who are allergic to the product and its ingredients; • Participants considered unsuitable for inclusion in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital sign;Laboratory index;electrocardiogram; | — |
Countries
China
Contacts
Public ContactHu Kaiwen
East Hospital of Beijing University of Chinese Medicine
Outcome results
None listed